A
A
Stallmach
D059451:Biosimilar Pharmaceuticals / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics*; D057915:Drug Substitution / Q000191:economics / Q000639:trends*; D019317:Evidence-Based Medicine; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics*; D005858:Germany; D006801:Humans; D016896:Treatment Outcome
D059451:Biosimilar Pharmaceuticals